Роль гипотензивной терапии верапамилом в предупреждении пароксизмов фибрилляции предсердий
Диссертация
Результаты настоящей работы могут найти, применение в практической деятельности поликлиник, кардиологических и терапевтических отделений стационаров, специализированных центров. Это позволяет индивидуализировать подход к обследованию' и лечению пациентов с артериальной гипертонией I-II степени и пароксизмальной формой фибрилляции предсердий и более широко применять верапамил пролонгированного… Читать ещё >
Список литературы
- Бокерия JI.A., Голухова Г. З., Бескровнов Ф. В. Возможная роль апоптоза в возникновении аритмий у больных с пароксизмальными тахикардиями // Кардиология.- 1995.- Т.35.- № 10.- С. 52−56
- Затейщиков Д.А. Эффективность и безопасность применения лизиноприла у пожилых пациентов, больных с сердечной недостаточностью и сахарным диабетом // Фарматека.- 2004. № 8.- С. 16
- Гришкин Ю.Н. Фрагментированная электрическая активность предсердий // Вестн. аритмол.- 1994, — № 3.- С. 33−37.
- Дощицин B.JI. Лечение аритмий сердца//Медицина.- 1993.-С.320.
- Бунин Ю.А. Лечение тахиаритмий сердца (практическая кардиология) //Москва «Боргес».- 2003.- С. 29.
- Дзяк Г. В., Локшин С. П. Мерцательная аритмия: современное состояние проблемы // Межд. мед. журн.- 1997.- № 3.- С. 6−9.
- Кушаковский М.С. Фибрилляция предсердий (причины, механизмы, клинические формы, лечение и профилактика).//- СПб. «Фолиант». 1999. — 176 с
- Мазур Н.А. Распространенность мерцательной аритмии (фибрилляции предсердий) у больных неревматическими заболеваниями сердца, влияние ее на прогноз жизни // Materia medica.- 1999, № 3−4,С. 48−51
- Марцевич С.Ю. Замедляющие пульс антагонисты кальция роль в современной терапии сердечно-сосудистых заболеваний // РМЖ, 2003, Том 11, № 15,С.-875−879
- Марцевич С.Ю. Антагонисты кальция: выбор терапии при артериальной гипертонии//Артериальная гипертензия, 2004, Том 10, № 4,С. 173−176
- Марцевич С.Ю. Роль антагонистов кальция в современном лечении сердечно-сосудистых заболеваний // РМЖ, 2003, Том 11, № 9,С. 53 9541j
- Явелов И.С. Особенности лечения мерцательной аритмии // РМЖ, 1998, Том 6, № 18,С. 1−2
- How to diagnose diastolic heart failure. European Study Group on Diastolic Heart Failure //Eur Heart J.- 1998.- vol. 19, p. 990−1003.
- New approaches to antiarrhythmic therapy, Part I: emerging therapeutic applications of the cell biology of cardiac arrhythmias //Circulation.- 2001.-vol. 104, p. 2865−2873.
- New approaches to antiarrhythmic therapy, Part I: emerging therapeutic applications of the cell biology of cardiac arrhythmias //Circulation.- 2001.-vol. 104, p. 2865−2873.
- New approaches to antiarrhythmic therapy, part II: emerging therapeutic applications of the cell biology of cardiac arrhythmias //Circulation.- 2001.-vol. 104, p. 2990−2994.
- New approaches to antiarrhythmic therapy, part II: emerging therapeutic applications of the cell biology of cardiac arrhythmias //Circulation.- 2001.-vol. 104, p. 2990−2994.
- Agati L., Fedele F., Penco M., Sciomer S., Dagianti A. Left ventricular filling pattern in hypertensive patients after reversal of myocardial hypertrophy //Int J Cardiol.- 1987.-vol. 17, p. 177−185.
- Agner E., Jans H. Verapamil as an anti-arrhythmic agent. Experience with 86 consecutive cases treated by intravenous injection. //Ugeskr Laeger.- 1977.-vol. 139, p. 2872−2876.
- Ahuja R. C., Sinha N., Saran R. K., Jain A. K., Hasan M. Digoxin or verapamil or metoprolol for heart rate control in patients with mitral stenosis-.-a randomised cross-over study //Int J Cardiol.- 1989.- vol. 25, p. 325−331.
- Antman E. M., Stone P. H., Muller J. E., Braunwald E. Calcium channel blocking agents in the treatment of cardiovascular disorders. Part I: Basic and clinical electrophysiologic effects //Ann Intern Med.- 1980.- vol. 93, p. 875 885.
- Aronow W. S., Ferlinz J. Verapamil versus placebo in atrial fibrillation and" atrial flutter //Clin Invest Med.- 1980.- vol. 3, p. 35−39.
- Aronow W. S., Landa D., Plasencia G., Wong R., Karlsberg R. P., Ferlinz J. Verapamil in atrial fibrillation and atrial flutter //Clin Pharmacol Ther.- 1979.-vol. 26, p. 578−583.
- Ausma J., Dispersyn G. D., Duimel H., Thone F., Ver Donck L., Allessie M. A., Borgers M. Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation //J Mol Cell Cardiol.- 2000.- vol. 32, p. 355−364.
- Ausma J., Wijffels M., Thone F., Wouters L., Allessie M., Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat//Circulation.- 1997.- vol. 96, p. 3157−3163.
- Barbier P., Alioto G., Guazzi M. D. Left atrial function and ventricular filling in hypertensive patients with paroxysmal atrial fibrillation //J Am Coll Cardiol.- 1994, — vol. 24, p. 165−170.
- Barbier P., Solomon S. В., Schiller N. В., Glantz S. A. Left atrial relaxation and left ventricular systolic function determine left atrial reservoir function //Circulation.- 1999.- vol. 100, p. 427−436.
- Beaumont J., Davidenko N., Davidenko J. M., Jalife J. Spiral waves in two-dimensional models of ventricular muscle: formation of a stationary core //Biophys J.- 1998.- vol. 75, p. 1−14.
- Belz G. G., Spies G. Controlled study on the treatment of hypertension with verapamil in retard form. HZ Kardiol.- 1985.- vol. 74, p. 453−459.
- Bolognesi R. The pharmacologic treatment of atrial fibrillation //Cardiovasc Drugs Ther.- 1991.- vol. 5, p. 617−628.
- Bonaduce D., Petretta M., Ianniciello A., Apicella C., Cavallaro V., Marciano F. Comparison of verapamil versus felodipine on heart rate variability after acute myocardial infarction //Am J Cardiol.- 1997.- vol. 79, p. 564−569.
- Bonow R. O., Udelson J. E. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management //Ann Intern Med.-1992.-vol. 117, p. 502−510.
- Boutarin J., Maarek-Charbit M., Aupetit J. F., Galey-Arcangioli C., Ritz B. Efficacy and tolerability of isoptine LP in mild to moderate hypertension. A multicenter study with 50 patients. //Ann Cardiol Angeiol (Paris).- 1992.- vol. 41, p. 587−593.
- Cabo C., Pertsov A. M., Davidenko J. M., Baxter W. Т., Gray R. A., Jalife J. Vortex shedding as a precursor of turbulent electrical activity in cardiac muscle //Biophys J.- 1996.- vol. 70, p. 1105−1111.
- Cabo C., Pertsov A. M., Davidenko J. M., Jalife J. Electrical turbulence as a result of the critical curvature for propagation in cardiac tissue //Chaos.- 1998.-vol. 8, p. 116−126.
- Ciaroni S., Cuenoud L., Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension //Am Heart J.- 2000.- vol. 139, p. 814−819.
- Courtemanche M., Ramirez R. J., Nattel S. Ionic mechanisms underlying human atrial action potential properties: insights from a mathematical model //Am J Physiol.- 1998.- vol. 275, p. H301−321.
- Dahlof В., Pennert K., Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies //Am J Hypertens.- 1992, — vol. 5, p. 95−110.
- Daoud E. G., Hummel J. D., Augostini R., Williams S., Kalbfleisch S. J. Effect of verapamil on immediate recurrence of atrial fibrillation //J Cardiovasc Electrophysiol.-2000.-vol. 11, p. 1231−1237.
- Davidenlco J. M., Pertsov A. V., Salomonsz R., Baxter W., Jalife J. Stationary and drifting spiral waves of excitation in isolated cardiac muscle //Nature.-1992.- vol. 355, p. 349−351.
- Davison R., Hartz R., Kaplan K., Parker M., Feiereisel P., Michaelis L. Prophylaxis of supraventricular tachyarrhythmia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial //Ann Thorac Surg.-1985.- vol. 39, p. 336−339.
- Dreslinski G. R., Frohlich E. D., Dunn F. G., Messerli F. H., Suarez D. H., Reisin E. Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying index //Am J Cardiol.- 1981.- vol. 47, p. 10 871 090.
- Elvan A., Huang X. D., Pressler M. L., Zipes D. P. Radiofrequency catheter. ablation- of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin 43 in dogs //Circulation.- 1997.- vol. 96, p. 1675−1685.
- Fareh S., Benardeau A., Nattel S. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs //Cardiovasc Res.- 2001.- vol. 49, p. 762−770.
- Fareh S., Benardeau A., Thibault В., Nattel S. The T-type Ca (2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs //Circulation.- 1999.- vol. 100, p. 2191−2197.
- Fast V. G., Kleber A. G. Role of wavefront curvature in propagation of cardiac impulse //Cardiovasc Res.- 1997.- vol. 33, p. 258−271.
- Fauchier L., Babuty D., Poret P., Autret M. L., Cosnay P., Fauchier J. P. Effect of verapamil on QT interval dynamicity //Am" J Cardiol.- 1999: — vol. 83, p. -807−808, A810−801.
- Forslund L., Bjorkander I., Ericson M., Held C., Kahan Т., Rehnqvist N., Hjemdahl P. Prognostic implications of autonomic function assessed by analyses of catecholamines and heart rate variability in stable angina pectoris //Heart 2002−87:415−422
- Galderisi M., Petrocelli A., Fakher A., Izzo A., Alfieri A., de Divitiis O. Influence of nighttime blood pressure on left atrial size in uncomplicated arterial systemic hypertension//Am J Hypertens.- 1997.- vol. 10, p. 836−842.
- Garrey W.E. Auricular fibrillation // Physiol Rev, 1924, vol.4, p.215−250
- Gaspo R., Bosch R. F., Bou-Abboud E., Nattel S. Tachycardia-induced changes in Na+ current in a chronic dog model of atrial fibrillation //Circ Res.-1997.- vol. 81, p. 1045−1052.
- Gaspo R., Bosch R. F., Talajic M., Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model //Circulation.- 1997.- vol. 96, p. 4027−4035.
- Gaspo R., Bosch R. F., Talajic M., Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model //Circulation.- 1997.- vol. 96, p. 4027−4035.
- Gaspo R, Bosch R. F., Talajic M., Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model //Circulation.- 1997.- vol. 96, p. 4027−4035.
- Gerdts E., Oikarinen L., Palmieri V., Otterstad J. E., Wachtell K., Boman K., Dahlof В., Devereux R. B. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint
- Reduction in Hypertension (LIFE) Study //Hypertension.- 2002.- vol. 39, p. 739−743.
- Goette A., Honeycutt C., Langberg J. J. Electrical remodeling in atrial fibrillation. Time course and mechanisms //Circulation.- 1996.- vol. 94, p. 2968−2974.
- Gonzalez-Gomez A., Cires Pujols M., Gamio Capestany F., Rodriguez de la Vega A., Garcia-Barreto D. Relationships between verapamil plasma concentrations and its antihypertensive action //Int J Clin Pharmacol Ther Toxicol.- 1988.- vol. 26, p. 453−460.
- Gonzalez R., Scheinman M. M. Treatment of supraventricular arrhythmias with intravenous and oral verapamil //Chest.- 1981.- vol. 80, p. 465−470.
- Gray R. J., Conklin С. M., Sethna D. H., Mandel W. J., Matloff J. M. Role of intravenous verapamil in supraventricular tachyarrhythmias after open-heartsurgery //Am Heart J.- 1982.- vol. 104, p. 799−802.i
- Guidera S. A., Steinberg J. S. The signal-averaged P wave duration: a rapid and noninvasive marker of risk of atrial fibrillation //J Am Coll Cardiol.-1993.- vol. 21, p. 1645−1651.
- Gullestad L., Birkeland K., Molstad P., Hoyer M. M., Vanberg P., Kjekshus J. The effect of magnesium versus verapamil on supraventricular arrhythmias //Clin Cardiol.- 1993.- vol. 16, p. 429−434.
- Han J., Мое G. K. Nonuniform Recovery Of Excitability In Ventricular Muscle //Circ Res.- 1964.- vol. 14, p. 44−60.
- Haney S., Sur D., Xu Z. Diastolic heart failure: a review and primary care perspective //J Am Board Fam Pract.- 2005.- vol. 18, p. 189−198.
- Hedback В., Hermann’L. S. Antihypertensive effect of verapamil in patients with newly discovered mild to moderate essential hypertension //Acta Med Scand Suppl.- 1984.- vol. 681, p. 129−135.
- Hedblad В., Janzon L. Hypertension and ST segment depression during ambulatory electrocardiographic recording. Results from the prospective population study 'men born in 1914' from Malmo, Sweden //Hypertension.-1992.- vol. 20, p. 32−37.
- Heidbuchel H! A paradigm shift in treatment for atrial fibrillation: from electrical to structural therapy? //Eur Heart J.- 2003.- vol. 24, p. 2077−2078.
- Howley J. W., Formolo J. M., Penney D. G. Structural and functional myocardial responses to chronic treatment with the Ca2+ blocker verapamil (Calan-SR) in hypertensive patients //J Cardiovasc Pharmacol.- 1993.- vol. 22, p. 637−643.
- Hund T. J., Otani N. F., Rudy Y. Dynamics of action potential head-tail interaction during reentry in cardiac tissue: ionic mechanisms //Am J Physiol Heart Circ Physiol.- 2000.- vol. 279, p. HI 869−1879.
- Incze A., Frigy A., Cotoi S. The efficacy of sublingual verapamil in controlling rapid ventricular rate in chronic atrial fibrillation //Rom J Intern Med.- 1998.-vol. 36, p. 219−225.
- Innes G. D., Vertesi L., Dillon E. C., Metcalfe C. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation //Ann Emerg Med.- 1997.- vol. 29, p. 126−134.
- Inouye I., Massie В., Loge D., Topic N., Silverstein D., Simpson P., Tubau J. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension //Am J Cardiol.- 1984.- vol. 53, p. 120−126.
- Ito О., Okamoto M., Murakami Y., Nakayama R. Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients. //J Cardiol.- 1991.- vol. 21, p. 931−941.
- Janse M. J., Wit A. L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction //Physiol Rev.-1989.-vol. 69, p. 1049−1169.
- Kamalvand K., Tan K., Lloyd G., Gill J., Bucknall C., Sulke N. Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man //Eur Heart J.- 1999, — vol. 20, p. 888−895.
- Kannel W. В., Wolf P. A., Benjamin E. J., Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates //Am J Cardiol.- 1998.- vol. 82, p. 2N-9N.
- Karlberg В. E., Andrup M., Oden A. Efficacy and safety of a new long-acting drug combination, trandolapril/verapamil as compared to monotherapy in primary hypertension. Swedish TARKA trialists //Blood Press.- 2000.- vol. 9, p. 140−145.
- Karma A. Electrical alternans and spiral wave breakup in cardiac tissue //Chaos.- 1994.- vol. 4, p. 461−472.
- Kass D. A., Bronzwaer J. G., Paulus W. J. What mechanisms underlie diastolic dysfunction in heart failure? //Circ Res.- 2004.- vol. 94, p. 1533−1542.
- Khalsa A., Olsson В., Henriksson B. A. Effect of oral verapamil on ventricular irregularity in long-standing atrial fibrillation //Acta Med Scand.- 1979.- vol. 205, p. 39−47.
- Kingma J. H., Suttorp M. J. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil //Am J Cardiol.- 1992.- vol. 70, p. 56A-60A- discussion 60A-61A.
- Kitzman D. W. Diastolic dysfunction in the elderly. Genesis and diagnostic and therapeutic implications //Cardiol Clin.- 2000.- vol. 18, p. 597−617, x.
- Kitzman D. W. Heart Failure in the Elderly: Systolic and Diastolic Dysfunction //Am J Geriatr Cardiol.- 1996.- vol. 5, p. 20−26.
- Kondili A., Kastrati A., Popa Y. Comparative evaluation of verapamil, flecainide and propafenone for the acute conversion of atrial fibrillation to sinus rhythm//Wien Klin Wochenschr.- 1990.- vol. 102, p. 510−513.
- Koylan N., Oncul A., Mercanoglu F., Orak E., Erzengin F., Buyukozturk K. The short-term effects of cilazapril on left ventricular diastolic function //J Cardiovasc Pharmacol.- 1994.- vol. 24 Suppl 3, p. S42−44.
- Krahn A. D., Manfreda J., Tate R. В., Mathewson F. A., Cuddy Т. E. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study //Am J Med.- 1995.- vol. 98, p. 476−484.
- Krinsky V., Pumir A. Models of defibrillation of cardiac tissue //Chaos.-1998.-vol. 8, p. 188−203.
- Lang R., Klein H. O., Weiss E., David D., Sareli P., Levy A., Guerrero J., Di Segni E., Kaplinsky E. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation//Chest.- 1983.- vol. 83, p. 491−499.
- Leistad E., Aksnes G., Verburg E., Christensen G. Atrial contractile dysfunction after short-term atrial fibrillation is reduced by verapamil but increased by BAY K8644 //Circulation.- 1996.- vol. 93, p. 1747−1754.
- Libretti A., Catalano M. Lipid profile during antihypertensive treatment. The SLIP Study Group. Study on Lipids with Isoptin Press //Drugs.- 1993.- vol. 46 Suppl 2, p. 16−23.
- Liebson P. R. Clinical studies of drug reversal of hypertensive left ventricular hypertrophy //Am J Hypertens.- 1990.- vol. 3, p. 512−517.
- Little W. C., Ohno M., Kitzman D. W., Thomas J. D., Cheng C. P. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling //Circulation.- 1995.- vol. 92, p. 1933−1939.
- Litwin S. E., Grossman W. Diastolic dysfunction as a cause of heart failure //J Am Coll Cardiol.- 1993.- vol. 22, p. 49A-55A.
- Lopez В., Gonzalez A., Varo N., Laviades C., Querejeta R., Diez J. Biochemical assessment of myocardial fibrosis in hypertensive heart disease //Hypertension.- 2001.- vol. 38, p. 1222−1226.
- Luciardi H, Berman S., Santana M., Monteros L. Intravenous diltiazem in the reversion to sinus rhythm in supraventricular tachyarrhythmias. //Arch Inst Cardiol Мех.- 1996.- vol. 66, p. 505−509.
- Lundstrom Т., Ryden L. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil //J Am Coll Cardiol.- 1990.-vol. 16, p. 86−90.
- Madu E. C., Baugh D. S., Gbadebo T. D., Dhala A., Cardoso S. Effect of ethnicity and hypertension on atrial conduction: evaluation with high-resolution P-wave signal averaging //Clin Cardiol.- 2001.- vol. 24, p. 597−602.
- Massie В. M., Fabi M. R. Clinical trials in diastolic heart failure //Prog Cardiovasc Dis.- 2005.- vol. 47, p. 389−395.
- Matsuda M., Matsuda Y. Mechanism of left atrial enlargement related to ventricular diastolic impairment in hypertension //Clin Cardiol.- 1996.- vol. 19, p. 954−959.
- Mayet J., Shahi M., Poulter N. R., Sever P. S., Foale R. A., Thorn S. A. Left ventricular diastolic function in hypertension: a 4 year follow-up study //Int J Cardiol.- 1995.-vol. 50, p. 181−188.
- Meyer Т., Boven К. H., Gunther E., Fejtl M. Micro-electrode arrays in cardiac safety pharmacology: a novel tool to study QT interval prolongation //Drug Saf.- 2004.- vol. 27, p. 763−772.
- Midtbo К., Hals О., Lauve О., van der Meer J., Storstein L. Studies on verapamil in the treatment of essential hypertension: a review //Br J Clin Pharmacol.- 1986.- vol.21 Suppl2, p. 165S-171S.
- Midtbo K., Hals O., van der Meer J., Storstein L., Lauve O. Instant and sustained-release verapamil in the treatment of essential hypertension //Am J Cardiol.- 1986.- vol. 57, p. 59D-63D.
- Midtbo K., Hals O., van der Meer J., Storstein L., Lauve O. Instant and sustained-release verapamil in the treatment of essential hypertension //Am J Cardiol.- 1986.- vol. 57, p. 59D-63D.
- Miller J. Т., O’Rourke R. A., Crawford M. H. Left atrial enlargement: an early sign of hypertensive heart disease //Am Heart J.- 1988.- vol. 116, p. 10 481 051.
- Мое G.K., Abildskov J. A. Atrial fibrillation as a self-sustaining arrhythmia independent of focal discharge //Am Heart J.- 1959.- vol. 58, p. 59−70.
- Morillo C. A., Klein G. J., Jones D. L., Guiraudon С. M. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation //Circulation.- 1995.- vol. 91, p. 15 881 595.
- Muijsers R. В., Curran M. P., Perry С. M. Fixed combination trandolapril/verapamil sustained-release: a review of its use in essential hypertension //Drugs.- 2002.- vol. 62, p. 2539−2567.
- Nattel S. Atrial electrophysiological remodeling caused by rapid atrial activation: underlying mechanisms and clinical relevance to atrial fibrillation //Cardiovasc Res.- 1999.- vol. 42, p. 298−308.
- Nattel S. Effects of ionic remodeling on cardiac antiarrhythmic drug actions //J Cardiovasc Pharmacol.- 2001.- vol. 38, p. 809−811.
- Nattel S. Therapeutic implications of atrial fibrillation mechanisms: can mechanistic insights be used to improve AF management? //Cardiovasc Res.-2002.- vol. 54, p. 347−360.
- Novo S., Alaimo G., Abrignani M. G., Longo В., Muratore G., Strano A. Noninvasive blood pressure monitoring evaluation of verapamil slow-release 240-mg antihypertensive effectiveness //J Cardiovasc Pharmacol.- 1989.- vol. 13 Suppl 4, p. S38−41.
- Ochs H. R., Anda L., Eichelbaum M., Greenblatt D. J. Diltiazem, verapamil, and quinidine in patients with chronic atrial fibrillation //J Clin Pharmacol.-1985.- vol. 25, p. 204−209.
- Owan Т. E., Redfield M. M. Epidemiology of diastolic heart failure //Prog Cardiovasc Dis.- 2005.- vol. 47, p. 320−332.
- Patten M., Maas R., Bauer P., Luderitz В., Sonntag F., Dluzniewski M., Hatala R., Opolski G., Muller H. W., Meinertz T. Suppression of paroxysmal atrial tachyarrhythmias-results of the SOPAT trial //Eur Heart J.- 2004.- vol. 25, p. 1395−1404.
- Perticone F., Maio R., Ceravolo R., Cosco C., Cloro C., Mattioli P. L. Relationship between left ventricular mass and endothelium-dependent vasodilation in never-treated hypertensive patients //Circulation.- 1999.- vol. 99, p. 1991−1996.
- Petrie J. R., Glen S. K., MacMahon M., Crome R., Meredith P. A., Elliott H. L., Reid J. L. Haemodynamics, cardiac conduction and pharmacokinetics of mibefradil (Ro 40−5967), a novel calcium antagonist //J Hypertens.- 1995.- vol. 13, p. 1842−1846.
- Pinar E., Garcia-Alberola A., Llamas C., Vicente Т., Lopez-Candel J., Rojo J. L., Fernandez R., Valdes M. Effects of verapamil on indexes of heart rate variability after acute myocardial infarction //Am J Cardiol.- 1998.- vol. 81, p. 1085−1089.
- Platia E. V., Michelson E. L., Porterfield J. K., Das G. Esmolol versus verapamil in the acute treatment of atrial- fibrillation or atrial flutter //Am J Cardiol.- 1989, — vol. 63- p. 925−929.
- Psaty В. M., Manolio T. A., Kuller L. H., Kronmal R. A., Cushman M., Fried L. P., White R., Furberg C. D., Rautaharju P: M. Incidence of and risk factors for atrial fibrillation in older adults //Circulation.- 1997.- vol. 96, p. 2455−2461.
- Quinones-M. A. Assessment of diastolic function //Prog Cardiovasc Dis.-2005.- vol. 47, p. 340−355.
- Ramirez R. J., Nattel S., Courtemanche M. Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling //Am J Physiol Heart Circ Physiol: — 2000.- vol. 279, p. H1767−1785.
- Rasmussen K., Wang H., Fausa D. Comparative efficiency of quinidine and verapamil in the maintenance of sinus rhythm after DC conversion of atrialfibrillation. A controlled clinical trial //Acta Med Scand Suppl.- 1981.- vol. 645, p. 23−28.
- Ravelli F., Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation, in the isolated Langendorff-perfiised rabbit heart//Circulation.- 1997.- vol. 96, p. 1686−1695.
- Rohr S., Kucera J. P., Kleber A. G. Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction //Circ Res.- 1998.- vol. 83, p. 781−794.
- Rosei E. A., Dal Palu C., Leonetti G., Magnani В., Pessina A., Zanchetti A. Clinical results of the Verapamil inHypertension and Atherosclerosis Study. VHAS Investigators //J Hypertens.- 1997.- vol. 15, p. 1337−1344.
- Sahin I., Kosar F., Altunkan S., Gunaydin M. Comparison of the effects of amlodipine and verapamil on autonomic activity in hypertensive patients// Eur J Intern Med. 2004 Jul-15(4):225−230.
- Satoh Т., Zipes D. P. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation //J Cardiovasc Electrophysiol.- 1996.- vol. 7, p. 833−842.
- Sau F., Seguro C., Alvau M. D., Pargentino E., Cherchi A. Effects of verapamil on left ventricular mass and diastolic function in hypertensive patients. //Cardiologia.- 1993.- vol. 38, p. 727−732.
- Schalij M.J. Anisotropic Conduction and Ventricular Tachycardia. Maastricht, The Netherlands: MD Rijksuniversiteit Limburg- 1988.
- Scheler S., Motz W., Strauer В. E. Transient myocardial ischaemia in hypertensives: missing link with left ventricular hypertrophy //Eur Heart J.-1992, — vol. 13 Suppl D, p. 62−65.
- Schuessler R. В., Kawamoto Т., Hand D. E., Mitsuno M., Bromberg В. I., Cox J. L., Boineau J. P. Simultaneous epicardial and endocardial activation sequence mapping in the isolated canine right atrium //Circulation: — 1993.- vol. 88, p. 250−263.
- Schulman S. P., Weiss J. L., Becker L. C., Gottlieb S. O., Woodruff К. M., Weisfeldt M. L., Gerstenblith G. The effects of antihypertensive therapy on left ventricular mass in elderly patients //N Engl J Med.- 1990, — vol. 322, p. 13 501 356.
- Shaw R. M., Rudy Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and' L-type calcium currents during reduced excitability and decreased gap junction coupling //Circ Res.- 1997.- vol. 81, p. 727−741.
- Sinno H., Derakhchan K., Libersan D., Merhi Y., Leung Т. K., Nattel S. Atrial ischemia promotes atrial fibrillation in dogs //Circulation.- 2003.- vol. 107, p. 1930−1936.
- Smith E. E., Shore D. F., Monro J. L., Ross J. K. Oral verapamil fails to prevent supraventricular tachycardia following coronary artery surgery //Int J Cardiol.- 1985.- vol. 9, p. 37−44.
- Smith V. E., Schulman P., Karimeddini M. K., White W. В., Meeran M. K., Katz A. M. Rapid ventricular filling in left ventricular hypertrophy: II. Pathologic hypertrophy //J Am Coll Cardiol.- 1985.- vol. 5, p. 869−874.
- Solti F., Vecsey Т., Kekesi V., Juhasz-Nagy A. The effect of atrial dilatation on the genesis of atrial arrhythmias //Cardiovasc Res.- 1989.- vol. 23, p. 882 886.
- Spring A., Haczynski J., Jolda-Mydlowska В.- Witkowska M. The effect of hypotensive drugs on left ventricular mass and diastolic function. //Pol Arch Med Wewn.- 1995.- vol. 94, p. 47−58.
- Spring A., Haczynski J., Jolda-Mydlowska В., Witkowska M. The effect of hypotensive drugs on left ventricular mass and diastolic function. //Pol Arch Med Wewn.- 1995.- vol. 94, p. 47−58.
- Spring A., Haczynski J., Jolda-Mydlowska В., Witkowska M. The effect of hypotensive drugs on left ventricular mass and diastolic function. //Pol Arch Med Wewn.- 1995.- vol. 94, p. 47−58.
- Spring A., Haczynski J., Jolda-Mydlowska В., Witkowska M. The effect of hypotensive drugs on left ventricular mass and diastolic function. //Pol Arch Med Wewn.- 1995.- vol. 94, p. 47−58.
- Starmer C. F., Biktashev V. N., Romashko D. N., Stepanov M. R., Makarova O. N., Krinsky V. I. Vulnerability in an excitable medium: analytical and numerical studies of initiating unidirectional propagation //Biophys J.- 1993.-vol. 65, p. 1775−1787.
- Stern E. H., Pitchon R., King B. D., Guerrero J., Schneider R. R., Wiener I. Clinical use of oral verapamil in chronic and paroxysmal atrial fibrillation //Chest.- 1982.- vol. 81, p. 308−311.
- Sun H., Chartier D'., Leblanc N., Nattel S. Intracellular calcium changes-and tachycardia-induced contractile dysfunction in canine atrial myocytes //Cardiovasc Res.- 2001.- vol. 49, p. 751−761.
- Sun H., Gaspo R., Leblanc N., Nattel S. Cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia //Circulation.-1998.- vol. 98, p. 719−727.
- Suttorp M. J., Kingma J. H., Lie A. Huen L., Mast E. G. Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm //Am J Cardiol.- 1989.- vol. 63, p. 693−696.
- Tedesco M. A., Di Salvo G., Ratti G., Natale F., Iarussi D., Iacono A. Left atrial size in 164 hypertensive patients: an echocardiographic and ambulatory blood pressure study //Clin Cardiol.- 2001.- vol. 24, p. 603−607.
- Tieleman R. G., De Langen C., Van Gelder I. C., de Kam P. J., Grandjean J., Bel K. J., Wijffels M. C., Allessie M. A., Crijns H. J. Verapamil reduces tachycardia-induced electrical remodeling of the atria //Circulation.- 1997.-vol. 95, p. 1945−1953.
- Tommaso C., McDonough Т., Parker M., Talano J. V. Atrial fibrillation and flutter. Immediate control and conversion with intravenously administered verapamil //Arch Intern Med.- 1983.- vol. 143, p. 877−881.
- Toshima H., Koga Y., Nagata H., Toyomasu K., Itaya K., Matoba T. Comparable effects of oral diltiazem and verapamil in the treatment, of hypertrophic cardiomyopathy. Double-blind crossover study //Jpn Heart J.-1986, — vol.27, p. 701−715.
- Tullo-N. G., Landau S., Goldman I., Coutinho N., Somberg J. A randomized comparative study of the electrophysiological and electrocardiographic effects of isradipine vs verapamil //Acta Anaesthesiol Scand Suppl.- 1993.- vol. 99, p. 43−47.
- Van Noord Т., Van Gelder I. C., Tieleman R. G., Bosker H. A., Tuinenburg A.
- Vaziri S. M., Larson M. G., Lauer M. S., Benjamin E. J., Levy D. Influence of blood pressure on left atrial size. The Framingham Heart Study //Hypertension.- 1995.- vol. 25, p. 1155−1160.
- Verdecchia P., Reboldi G., Gattobigio R., Bentivoglio M., Borgioni C., Angeli
- F., Carluccio E., Sardone M. G., Porcellati C. Atrial fibrillation in hypertension: predictors and outcome //Hypertension.- 2003.- vol. 41, p. 218 223.
- Villari В., Campbell S. E., Hess О. M., Mall G., Vassalli G., Weber К. Т., Krayenbuehl H. P. Influence of collagen network on left ventricular systolic and diastolic function in aortic valve disease //J Am Coll Cardiol.- 1993.- vol. 22, p. 1477−1484.
- Vinet A., Roberge F. A. The dynamics of sustained reentry in a ring model of cardiac tissue //Ann Biomed Eng.- 1994.- vol. 22, p. 568−591.
- Widimsky J. The fixed combination of verapamil SR/trandolapril //Expert Opin Pharmacother.- 2000.- vol. 1, p. 515−535.
- Wijffels M. C., Kirchhof C. J., Dorland R., Allessie M. A. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats //Circulation.- 1995.-vol. 92, p. 1954−1968.
- Winfree A. T. Varieties of spiral wave behavior: An experimentalist’s approach to the theory of excitable media //Chaos.- 1991.- vol. 1, p. 303−334.
- Yturralde R. F., Gaasch W. H. Diagnostic criteria for diastolic heart failure //Prog Cardiovasc Dis.- 2005.- vol. 47, p. 314−319.
- Yu W. C, Chen S. A., Lee S. H., Tai С. Т., Feng A. N., Kuo В. I., Ding Y. A., Chang M. S. Tachycardia-induced change of atrial refractory period in humans: rate dependency and effects of antiarrhythmic drugs //Circulation.-1998.-vol. 97, p. 2331−2337.
- Yue L., Feng J., Gaspo R., Li G. R., Wang Z., Nattel S. Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation //Circ Res.- 1997.- vol. 81, p. 512−525.
- Yue L., Melnyk P., Gaspo R., Wang Z., Nattel S. Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation //Circ Res.-1999.- vol. 84, p. 776−784.
- Zanchetti A. Vascular complications in hypertension: the VHAS study. Verapamil-Hypertension Atherosclerosis Study //Cardiovasc Drugs Ther.-1995.- vol. 9 Suppl 3, p. 529−531.
- Zanchetti A., Magnani В., Dal Palu C. Atherosclerosis and calcium antagonists: the VHAS. The Verapamil-Hypertension Atherosclerosis Study (VHAS) Investigators //J Hum Hypertens.- 1992.- vol. 6 Suppl 2, p. S45−48.
- Zile M. R. Diastolic heart failure. Diagnosis, prognosis, treatment //Minerva Cardioangiol.- 2003.- vol. 51, p. 131−142.
- Zile M. R., Baicu C. F., Bonnema D. D. Diastolic heart failure: definitions and terminology //Prog Cardiovasc Dis.- 2005.- vol. 47, p. 307−313.
- Zile M. R., Brutsaert D. L. New concepts in diastolic dysfunction and diastolic heart failure: Part I: diagnosis, prognosis, and measurements of diastolic function //Circulation.- 2002.- vol. 105, p. 1387−1393.
- Zile M. R., Brutsaert D. L. New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment //Circulation.- 2002.-vol. 105, p. 1503−1508.